105

Chipping Away at the Crisis (Part 2): Navigating Alzheimer’s from Diagnosis to Care with Dr. Jason Karlawish

Host Meryl Comer continues her conversation with Dr. Jason Karlawish, professor of medicine, medical ethics, and neurology at the University of Pennsylvania, about the evolving

LISTEN NOW
44

Lily Johnson White – Breaking Through the Silence of Alzheimer’s Disease

The Alzheimer’s journey tests and complicates the interpersonal dynamics in families as they try to protect the dignity and privacy of their loved ones. When

LISTEN NOW
43

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm

LISTEN NOW
42

John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs

Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke

LISTEN NOW
41

Amy Dockser Marcus, Author of "We the Scientists" (part 2)

We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine

In Part 2 of the interview with

LISTEN NOW
40

Amy Dockser Marcus, Author of "We the Scientists" (part 1)

We the Scientists: How a Daring Team of Parents and Doctors Forged A New Path for Medicine

Pulitzer Prize winning Wall Street Reporter Amy Marcus, in

LISTEN NOW